Top

Virology Journal

Published in:

Open Access 01-12-2013 | Research

No association between XMRV or related gammaretroviruses in Australian prostate cancer patients

Authors: Simin D Rezaei, Anna C Hearps, John Mills, John Pedersen, Gilda Tachedjian

Published in: Virology Journal | Issue 1/2013

Abstract

Background

Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus reported to be associated with prostate cancer (PC) and chronic fatigue syndrome (CFS). While the association of XMRV with CFS and PC has recently been discredited, no studies have been performed in Australian patients to investigate the association between PC and XMRV or related murine leukemia virus (MLV) in matched PC and normal tissue.

Methods

Genomic DNA (gDNA) was purified from matched normal and cancer formalin-fixed paraffin-embedded (FFPE) prostate tissue from 35 Australian PC patients with Gleason scores ranging from 7 – 10. The presence of the ribonuclease L (RNase L) polymorphism R462Q was determined by allele specific PCR. Samples were screened for XMRV and related murine leukemia virus (MLV) variants by qPCR. Contaminating mouse DNA was detected using qPCR targeting mouse intracisternal A particle long terminal repeat DNA.

Results

gDNA was successfully purified from 94% (66/70) of normal and cancer FFPE prostate tissues. RNase L typing revealed 8% were homozygous (QQ), 60% were heterozygous (RQ) and 32% were wild-type (RR) for the RNase L mutation. None of the 66 samples tested were positive for XMRV or related MLV sequences using broad MLV or XMRV specific primers with detection sensitivities of 1 viral copy of MLV/XMRV and XMRV DNA, respectively.

Conclusions

Using highly sensitive qPCR we found no evidence of XMRV or related gammaretroviruses in prostate tissues from 35 Australian PC patients. Our findings are consistent with other studies demonstrating that XMRV is a laboratory contaminant that has no role in the aetiology of PC.

Available only for authorised users

Silverman RH, Nguyen C, Weight CJ, Klein EA: The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol 2010, 7: 392-402. 10.1038/nrurol.2010.77PubMedCrossRef

Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi RL: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2: e25. 10.1371/journal.ppat.0020025PubMedPubMedCentralCrossRef

Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA: XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010, 75: 755-761. 10.1016/j.urology.2010.01.038PubMedCrossRef

Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009, 106: 16351-16356. 10.1073/pnas.0906922106PubMedPubMedCentralCrossRef

Danielson BP, Ayala GE, Kimata JT: Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 2010, 202: 1470-1477. 10.1086/656146PubMedPubMedCentralCrossRef

Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326: 585-589. 10.1126/science.1179052PubMedCrossRef

Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB: A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 2008, 68: 306-320. 10.1002/pros.20680PubMedCrossRef

D’Arcy F, Foley R, Perry A, Marignol L, Lawler M, Gaffney E, Watson RGW, Fitzpatrick JM, Lynch TH: No evidence of XMRV in Irish prostate cancer patients with the R462Q mutation. Eur Urol Suppl 2008, 7: 271.CrossRef

Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T: Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008, 43: 277-283. 10.1016/j.jcv.2008.04.016PubMedCrossRef

10.

Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N: Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009, 6: 92. 10.1186/1742-4690-6-92PubMedPubMedCentralCrossRef

11.

Sakuma T, Hue S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y: No evidence of XMRV in prostate cancer cohorts in the Midwestern United States. Retrovirology 2011, 8: 23. 10.1186/1742-4690-8-23PubMedPubMedCentralCrossRef

12.

Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A: XMRV: a new virus in prostate cancer? Cancer Res 2010, 70: 10028-10033. 10.1158/0008-5472.CAN-10-2837PubMedPubMedCentralCrossRef

13.

Switzer WM, Jia H, Zheng H, Tang S, Heneine W: No association of xenotropic murine leukemia virus-related viruses with prostate cancer. PLoS One 2011, 6: e19065. 10.1371/journal.pone.0019065PubMedPubMedCentralCrossRef

14.

Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordonez MA, Calderon-Cardenas G, Ortiz-Lopez R, Rivas-Estilla AM, Ancer-Rodriguez J, Rojas-Martinez A: Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 2010, 10: 326. 10.1186/1471-2407-10-326PubMedPubMedCentralCrossRef

15.

Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, Schalken JA: Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 2011, 71: 415-420. 10.1002/pros.21255PubMedCrossRef

16.

Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, Sato E, Misawa N, Nakatomi Y, Sakuma R, Yasui K, Yamaguti K, Hirayama F: No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 2011, 8: 20. 10.1186/1742-4690-8-20PubMedPubMedCentralCrossRef

17.

Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, Simon R, Minner S, Schindler M, Fischer N: No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe. PLoS One 2011, 6: e25592. 10.1371/journal.pone.0025592PubMedPubMedCentralCrossRef

18.

Robinson MJ, Tuke PW, Erlwein O, Tettmar KI, Kaye S, Naresh KN, Patel A, Walker MM, Kimura T, Gopalakrishnan G, Tedder RS, McClure MO: No Evidence of XMRV or MuLV sequences in prostate cancer, diffuse large B-cell lymphoma, or the UK blood donor population. Adv Virol 2011, 2011: 782353.PubMedPubMedCentralCrossRef

19.

Mendoza R, Silverman RH, Klein EA, Miller AD: No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients. PLoS One 2012, 7: e36073. 10.1371/journal.pone.0036073PubMedPubMedCentralCrossRef

20.

Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, Coffin JM, Huber BT: Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010, 7: 109. 10.1186/1742-4690-7-109PubMedPubMedCentralCrossRef

21.

Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO: Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010, 7: 108. 10.1186/1742-4690-7-108PubMedPubMedCentralCrossRef

22.

Sato E, Furuta RA, Miyazawa T: An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 2010, 7: 110. 10.1186/1742-4690-7-110PubMedPubMedCentralCrossRef

23.

Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS: PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS One 2011, 6: e19953. 10.1371/journal.pone.0019953PubMedPubMedCentralCrossRef

24.

Erlwein O, Robinson MJ, Dustan S, Weber J, Kaye S, McClure MO: DNA extraction columns contaminated with murine sequences. PLoS One 2011, 6: e23484. 10.1371/journal.pone.0023484PubMedPubMedCentralCrossRef

25.

Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ: Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010, 7: 111. 10.1186/1742-4690-7-111PubMedPubMedCentralCrossRef

26.

Garson JA, Kellam P, Towers GJ: Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011, 8: 13. 10.1186/1742-4690-8-13PubMedPubMedCentralCrossRef

27.

Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ Jr, Coffin JM, Pathak VK: Recombinant origin of the retrovirus XMRV. Science 2011, 333: 97-101. 10.1126/science.1205292PubMedPubMedCentralCrossRef

28.

Shin CH, Bateman L, Schlaberg R, Bunker AM, Leonard CJ, Hughen RW, Light AR, Light KC, Singh IR: Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol 2011, 85: 7195-7202. 10.1128/JVI.00693-11PubMedPubMedCentralCrossRef

29.

Oakes B, Qiu X, Levine S, Hackett J Jr, Huber BT: Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays. Adv Virol 2011, 2011: 854540.PubMedPubMedCentralCrossRef

30.

Dupressoir A, Heidmann T: Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice. Oncogene 1997, 14: 2951-2958. 10.1038/sj.onc.1201148PubMedCrossRef

31.

Das Gupta J, Luk KC, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J Jr, Silverman RH: Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1. PLoS One 2012, 7: e36072. 10.1371/journal.pone.0036072PubMedPubMedCentralCrossRef

32.

Diaz-Guerra M, Rivas C, Esteban M: Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 1997, 236: 354-363. 10.1006/viro.1997.8719PubMedCrossRef

33.

Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC, Torrence PF, Youle RJ: A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 1997, 186: 967-972. 10.1084/jem.186.6.967PubMedPubMedCentralCrossRef

34.

Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS: RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002, 32: 581-583. 10.1038/ng1021PubMedCrossRef

35.

Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN: Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002, 71: 116-123. 10.1086/341281PubMedPubMedCentralCrossRef

36.

Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM, Busch MP: The blood xenotropic murine leukemia virus-related virus scientific research working group: mission, progress, and plans. Transfusion 2011, 51: 643-653. 10.1111/j.1537-2995.2011.03063.xPubMedPubMedCentralCrossRef

37.

Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J Jr, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP: Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 2011, 334: 814-817. 10.1126/science.1213841PubMedPubMedCentralCrossRef

38.

Alberts B: Retraction. Science 2011, 334: 1636.PubMedCrossRef

39.

Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH: An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007, 104: 1655-1660. 10.1073/pnas.0610291104PubMedPubMedCentralCrossRef

40.

Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hacket J, Silverman RH, Chiu CY: In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer. PLoS One 2012, 7: e44954. 10.1371/journal.pone.0044954PubMedPubMedCentralCrossRef

41.

Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI: A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. MBio 2012, 3: e00266-12.PubMedPubMedCentralCrossRef

42.

Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, Marengo SR, Rhim JS, Zhang D, Jacobberger JW: A new human prostate carcinoma cell line, 22Rv1. Vitro Cell Dev Biol Anim 1999, 35: 403-409. 10.1007/s11626-999-0115-4CrossRef

43.

Jacobs JP, Jones CM, Baille JP: Characteristics of a human diploid cell designated MRC-5. Nature 1970, 227: 168-170. 10.1038/227168a0PubMedCrossRef

44.

Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978, 21: 274-281. 10.1002/ijc.2910210305PubMedCrossRef

45.

Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43: 1809-1818.PubMed

46.

Colicelli J, Goff SP: Sequence and spacing requirements of a retrovirus integration site. J Mol Biol 1988, 199: 47-59. 10.1016/0022-2836(88)90378-6PubMedCrossRef

47.

Zhang YA, Maitra A, Hsieh JT, Rudin CM, Peacock CD, Karikari C, Brekken RA, Stastny V, Gao B, Girard L, Wistuba I, Frenkel E, Minna JD, Gazdar AF: Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther 2011, 12: 617-628. 10.4161/cbt.12.7.15955PubMedPubMedCentralCrossRef

Title: No association between XMRV or related gammaretroviruses in Australian prostate cancer patients
Authors: Simin D Rezaei
Anna C Hearps
John Mills
John Pedersen
Gilda Tachedjian
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-10-20

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Development of a quick and simple detection methodology for foot-and-mouth disease virus serotypes O, A and Asia 1 using a generic RapidAssay Device

Frequent detection of Merkel cell polyomavirus DNA in sera of HIV-1-positive patients

A reported death case of a novel bunyavirus in Shanghai, China

Posttranslational modifications and secretion efficiency of immunogenic hepatitis B virus L protein deletion variants

Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes

A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials